Antimetastatic Properties of Prodigiosin and the BH3-Mimetic Obatoclax (GX15-070) in Melanoma
Metastasis is the primary cause of death in cancer patients. Many current chemotherapeutic agents only show cytotoxic, but not antimetastatic properties. This leads to a reduction in tumor size, but allows cancer cells to disseminate, which ultimately causes patient death. Therefore, novel anticance...
Saved in:
Main Authors: | Margarita Espona-Fiedler (Author), Pilar Manuel-Manresa (Author), Cristina Benítez-García (Author), Pere Fontova (Author), Roberto Quesada (Author), Vanessa Soto-Cerrato (Author), Ricardo Pérez-Tomás (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of anisomycin, prodigiosin and obatoclax as compounds with broad-spectrum anti-parasitic activity.
by: Gretchen Ehrenkaufer, et al.
Published: (2020) -
BH3 Mimetics for the Treatment of Prostate Cancer
by: Philipp Wolf
Published: (2017) -
Hypericin, a potential new BH3 mimetic
by: Anastasia Doroshenko, et al.
Published: (2022) -
Effect of the BH3 Mimetic Polyphenol (-)-Gossypol (AT-101) on the in vitro and in vivo Growth of Malignant Mesothelioma
by: Monica Benvenuto, et al.
Published: (2018) -
S1, a Novel Pan-BH3 Mimetic, Induces Apoptosis in Mcl-1-Overexpressing Cells Through Bak
by: Ting Song, et al.
Published: (2012)